biosimilar

Biosimilar drugs to gain greater priority as decade progresses

This is a guest post from Keith Bradbury, Executive Director of Drug Information at Medco Health Solutions, Inc. Biosimilar drugs […]

Biosimilar drugs to gain greater priority as decade progresses Read Post »

General Biotechnology

Jim Greenwood on Data Exclusivity and Healthcare Innovation

Biotechnology Industry Organization CEO Jim Greenwood appeared on CNBC’s SquawkBox defending the case for data exclusivity protection for novel biologic

Jim Greenwood on Data Exclusivity and Healthcare Innovation Read Post »